REFERENCES
- Williams D. Susceptibility testing. Antibiot Chemother 1997; 1: 15-16.
- Periti P. Farmacocinetica clinica. In: Farmacologia Clinicae Chemioterapia (Giotti A, Genazzani E, Pepeu G et al. Eds), 3rd Ed. UTET, Torino 1994: 85-97.
- Goldstein F, Soussy C-J, Thabaut A. Definition of the clinical antibacterial spectrum of activity. Clin Microbiol Infect 1996; 2 (Suppl 1): S40-S45.
- Chabbert YÀ. Sensibilité bacterienne aux antibiotiques. In: Bactériologie Médicale (Le Minor L, Véron M, Eds). Flammarion, Paris 1982: 204-212.
- Courvalin P. Interpretive reading of in vitro antibiotic susceptibility tests (the antibiogramme). Clin Microbiol Infect 1996; 2 (Suppl 1): S26-S34.
- Nix DE, Goodwin SD, Peloquin CA, Rotella DL, Schentag JJ. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrob Agents Chemother 1991; 35: 1953-1959.
- Mini E, Novelli A, Periti P. Concentration-effect relationship for antimicrobial drugs. Proceedings of the First International Conference on Progress in Pathogen-Antibiotic Interactions. Turin, Italy - September 21-23, 1989. J Chemother 1991; 3 (Suppl 1): 149-154.
- Novelli A, Ciuffi M, Reali UM, Mazzei T, Periti P. The suction blister technique as a tool in antimicrobial drug pharmacokinetics. Drugs Exp Clin Res 1983; 9: 555-559.
- Mazzei T, Periti P. Tissue distribution of antimicrobial drugs. J Chemother 1989; 1 (2): 75-79.
- Zack O, O'Reilly T. Animal models as predictors of the safery and efficacy of antibiotics. Eur J Clin Microbiol Infect Dis 1990; 9 (7): 472-478.
- Tramont EC. General or nonspecific host defense mechanisms. In: Principles and Practice of Infectious Diseases (Mandell GL, Douglas RG, Bennett JE, Eds), Third Ed. Churchill Livingstone, New York 1990: 33-41.
- Nichols WW. Towards a fundamental understanding of the MIC of (3-lactam antibiotics. J Antimicrob Chemother 1988;22:275-283.
- Brown MRW, Collier PJ, Gilbert P. Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother 1990; 34 (9): 1623-1628.
- Mouton Y, Senneville E. Broad- versus narrow-spectrum antibiotic use: the role of in vitro testing and its correlation with clinical efficacy. Postgrad Med J 1992; 68 (Suppl 3): S68-S72.
- Thornsberry C. Cefaclor AF: correlation of microbiology and clinical outcome. Postgrad Med [1992] 68 (Suppl 3): S10-S16.
- Wiedemann B. European Study Group on Antibiotic Breakpoints. Breakpoint determination: cefepime. Eur I Clin Microbiol Infect Dis 1994; 13 (3): 282-283.
- Shah PM, Schäfer V, Ziemen M, Krauskopf S, and Microbiological and Clinical Study Group. Comparison of clinical response to cefpirome treatment and minimum inhibitory concentration of causative isolates. J Antimicrob Chemother 1992; 29 (Suppl A): 75-80.
- Bryan LE. Leading article. Two forms of antimicrobial resistance: bacterial persistence and positive function resistance. J Antimicrob Chemother 1989; 23: 817-823.
- Greenwood D. Leading article. Phenotypic resistance to antimicrobial agents. J Antimicrob Chemother 1985; 15: 653-658.